Counts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Showing 5 stories from April 2026
Show allThe items moving the net sentiment the most, by direction and influence.
Pakistan Drug Testing Lab Gets WHO Approval: Boost for Pharma Sector Stocks
Global demand / recession risk · Medium influence · Long term
Soaring Drug Prices in KP: Positive for Pakistan Pharma Stocks
Direct news · Medium influence · Long term
Pakistan Pharma Profits Hit Record Rs42 Billion in 2025 on Deregulation: Searle, Abbott, AGP, Highnoon
Direct news · Medium influence · Long term
Senate Panel Raises Alarm Over Drug Prices: Pharma Stocks Face Pricing Pressure
Drug pricing (DRAP) · Medium influence · Long term
Macro, commodity, FX and regulatory forces that moved HINOON in this range, with the stories behind each.
Sign up free to track HINOON, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track HINOON for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Also monitored for HINOON (no news in this range): PKR/USD exchange rate, Consumer demand & purchasing power.
How news sentiment on Highnoon Laboratories (HINOON) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
